Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Invitrogen Corp (IVGN) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Invitrogen Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1073431.
Total stock buying since 2010: $786,750.
Total stock sales since 2010: $46,950,597.
Total stock option exercises since 2010: $71,620,531.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2013 | 0 | $0 | 62,010 | $4,591,610 | 493,409 | $25,585,304 |
| 2012 | 3,330 | $154,815 | 256,072 | $12,729,060 | 858,739 | $24,661,219 |
| 2011 | 15,750 | $631,935 | 84,727 | $4,523,303 | 269,272 | $10,068,486 |
| 2010 | 0 | $0 | 484,568 | $25,106,624 | 368,709 | $11,305,522 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2013-12 | 0 | $0 | 0 | $0 | 76,000 | $1,689,480 |
| 2013-09 | 0 | $0 | 0 | $0 | 2,404 | $179,290 |
| 2013-08 | 0 | $0 | 0 | $0 | 1,726 | $129,070 |
| 2013-05 | 0 | $0 | 62,010 | $4,591,610 | 60,000 | $1,831,800 |
| 2013-04 | 0 | $0 | 0 | $0 | 191,475 | $12,991,497 |
| 2013-03 | 0 | $0 | 0 | $0 | 158,232 | $8,531,130 |
| 2013-02 | 0 | $0 | 0 | $0 | 3,572 | $233,037 |
| 2012-12 | 0 | $0 | 20,000 | $1,021,240 | 527,352 | $9,945,560 |
| 2012-11 | 0 | $0 | 18,246 | $882,502 | 161,943 | $7,970,834 |
| 2012-10 | 0 | $0 | 6,958 | $337,602 | 6,958 | $160,034 |
| 2012-09 | 0 | $0 | 169,868 | $8,493,400 | 3,828 | $184,547 |
| 2012-05 | 0 | $0 | 20,000 | $934,300 | 20,000 | $351,200 |
| 2012-04 | 3,330 | $154,815 | 0 | $0 | 116,484 | $5,593,101 |
| 2012-03 | 0 | $0 | 500 | $23,189 | 2,174 | $104,743 |
| 2012-02 | 0 | $0 | 500 | $23,827 | 0 | $0 |
| 2012-01 | 0 | $0 | 20,000 | $1,013,000 | 20,000 | $351,200 |
| 2011-11 | 0 | $0 | 2,474 | $90,894 | 136,076 | $4,993,987 |
| 2011-10 | 0 | $0 | 0 | $0 | 4,052 | $150,774 |
| 2011-08 | 15,550 | $620,887 | 0 | $0 | 13,232 | $431,724 |
| 2011-06 | 0 | $0 | 1,000 | $51,040 | 1,000 | $31,860 |
| 2011-05 | 200 | $11,048 | 4,000 | $221,752 | 14,720 | $817,994 |
| 2011-04 | 0 | $0 | 0 | $0 | 23,439 | $1,311,645 |
| 2011-03 | 0 | $0 | 33,342 | $1,684,937 | 33,342 | $943,351 |
| 2011-02 | 0 | $0 | 500 | $26,863 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-12-18 | Stevenson Mark (President & COO) | Option Ex | 76,000 | 22.23 | 1,689,480 |
| 2013-09-03 | Leddy Peter Michael (SVP, Global Human Resources) | Option Ex | 2,404 | 74.58 | 179,290 |
| 2013-08-01 | Richard Kelli (Chief Accounting Officer) | Option Ex | 1,726 | 74.78 | 129,070 |
| 2013-05-29 | Uprichard David C (Director) | Sale | 2,010 | 74.04 | 148,820 |
| 2013-05-28 | Cottingham John A (Chief Legal Officer) | Sale | 30,000 | 74.23 | 2,226,840 |
| 2013-05-28 | Cottingham John A (Chief Legal Officer) | Option Ex | 30,000 | 30.53 | 915,900 |
| 2013-05-24 | Cottingham John A (Chief Legal Officer) | Sale | 30,000 | 73.86 | 2,215,950 |
| 2013-05-24 | Cottingham John A (Chief Legal Officer) | Option Ex | 30,000 | 30.53 | 915,900 |
| 2013-04-29 | Iyer Balakrishnan S (Director) | Option Ex | 4,888 | 73.68 | 360,147 |
| 2013-04-26 | Uprichard David C (Director) | Option Ex | 4,888 | 73.74 | 360,441 |
| 2013-04-25 | Lorimier Bradley G (Director) | Option Ex | 31,964 | 73.70 | 2,355,746 |
| 2013-04-25 | Levine Arnold J (Director) | Option Ex | 19,432 | 73.70 | 1,432,138 |
| 2013-04-24 | Levine Arnold J (Director) | Option Ex | 1,222 | 73.70 | 90,061 |
| 2013-04-02 | Stevenson Mark (President & COO) | Option Ex | 10,479 | 65.75 | 688,994 |
| 2013-04-02 | Leddy Peter Michael (SVP, Global Human Resources) | Option Ex | 3,067 | 65.75 | 201,655 |
| 2013-04-02 | Hoffmeister David F (Chief Financial Officer) | Option Ex | 5,112 | 65.75 | 336,114 |
| 2013-04-02 | Andrews Ronald Asbury (President, Medical Sciences) | Option Ex | 3,067 | 65.75 | 201,655 |
| 2013-04-02 | Richard Kelli (Chief Accounting Officer) | Option Ex | 1,534 | 65.75 | 100,860 |
| 2013-04-02 | Lucier Gregory T (Chief Executive Officer) | Option Ex | 23,002 | 65.75 | 1,512,381 |
| 2013-04-02 | Cottingham John A (Chief Legal Officer) | Option Ex | 3,067 | 65.75 | 201,655 |
| 2013-04-01 | Stevenson Mark (President & COO) | Option Ex | 18,765 | 64.57 | 1,211,656 |
| 2013-04-01 | Leddy Peter Michael (SVP, Global Human Resources) | Option Ex | 5,630 | 64.57 | 363,529 |
| 2013-04-01 | Hoffmeister David F (Chief Financial Officer) | Option Ex | 9,383 | 64.57 | 605,860 |
| 2013-04-01 | Richard Kelli (Chief Accounting Officer) | Option Ex | 2,815 | 64.57 | 181,764 |
| 2013-04-01 | Lucier Gregory T (Chief Executive Officer) | Option Ex | 37,530 | 64.57 | 2,423,312 |
| 2013-04-01 | Cottingham John A (Chief Legal Officer) | Option Ex | 5,630 | 64.57 | 363,529 |
| 2013-03-08 | Dittamore Raymond V (Director) | Option Ex | 20,000 | 15.04 | 300,800 |
| 2013-03-01 | Stevenson Mark (President & COO) | Option Ex | 24,509 | 59.54 | 1,459,265 |
| 2013-03-01 | Leddy Peter Michael (SVP, Global Human Resources) | Option Ex | 11,764 | 59.54 | 700,428 |
| 2013-03-01 | Hoffmeister David F (Chief Financial Officer) | Option Ex | 19,607 | 59.54 | 1,167,400 |
| 2013-03-01 | Richard Kelli (Chief Accounting Officer) | Option Ex | 5,882 | 59.54 | 350,214 |
| 2013-03-01 | Lucier Gregory T (Chief Executive Officer) | Option Ex | 70,588 | 59.54 | 4,202,809 |
| 2013-03-01 | Cottingham John A (Chief Legal Officer) | Option Ex | 5,882 | 59.54 | 350,214 |
| 2013-02-01 | Andrews Ronald Asbury (President, Medical Sciences) | Option Ex | 3,572 | 65.24 | 233,037 |
| 2012-12-27 | Lucier Gregory T (Chief Executive Officer) | Option Ex | 150,655 | 19.01 | 2,863,951 |
| 2012-12-26 | Lucier Gregory T (Chief Executive Officer) | Option Ex | 356,697 | 19.01 | 6,780,809 |
| 2012-12-11 | Lorimier Bradley G (Director) | Sale | 20,000 | 51.06 | 1,021,240 |
| 2012-12-11 | Lorimier Bradley G (Director) | Option Ex | 20,000 | 15.04 | 300,800 |
| 2012-11-21 | Lucier Gregory T (Chief Executive Officer) | Option Ex | 161,943 | 49.22 | 7,970,834 |
| 2012-11-20 | Grimm Donald W (Director) | Sale | 8,000 | 47.98 | 383,840 |
| 2012-11-19 | Grimm Donald W (Director) | Sale | 4,052 | 47.86 | 193,912 |
| 2012-11-06 | Richard Kelli (Chief Accounting Officer) | Sale | 6,194 | 49.20 | 304,750 |
| 2012-10-15 | Levine Arnold J (Director) | Sale | 6,958 | 48.52 | 337,602 |
| 2012-10-15 | Levine Arnold J (Director) | Option Ex | 6,958 | 23.00 | 160,034 |
| 2012-09-18 | Lucier Gregory T (Chief Executive Officer) | Sale | 169,868 | 50.00 | 8,493,400 |
| 2012-09-04 | Leddy Peter Michael (SVP, Global Human Resources) | Option Ex | 2,404 | 48.21 | 115,896 |
| 2012-09-04 | Richard Kelli (Chief Accounting Officer) | Option Ex | 1,424 | 48.21 | 68,651 |
| 2012-05-01 | Lorimier Bradley G (Director) | Sale | 20,000 | 46.72 | 934,300 |
| 2012-05-01 | Lorimier Bradley G (Director) | Option Ex | 20,000 | 17.56 | 351,200 |
| 2012-04-30 | Dittamore Raymond V (Director) | Option Ex | 4,021 | 46.36 | 186,413 |
| 2012-04-27 | Andrews Ronald Asbury (President, Medical Sciences) | Buy | 3,330 | 46.49 | 154,815 |
| 2012-04-26 | Longfield William H (Director) | Option Ex | 32,709 | 46.04 | 1,505,922 |
| 2012-04-02 | Stevenson Mark (President & COO) | Option Ex | 18,765 | 48.91 | 917,796 |
| 2012-04-02 | Leddy Peter Michael (SVP, Global Human Resources) | Option Ex | 5,630 | 48.91 | 275,363 |
| 2012-04-02 | Hoffmeister David F (Chief Financial Officer) | Option Ex | 9,383 | 48.91 | 458,922 |
| 2012-04-02 | Richard Kelli (Chief Accounting Officer) | Option Ex | 2,815 | 48.91 | 137,681 |
| 2012-04-02 | Lucier Gregory T (Chief Executive Officer) | Option Ex | 37,531 | 48.91 | 1,835,641 |
| 2012-04-02 | Cottingham John A (Chief Legal Officer) | Option Ex | 5,630 | 48.91 | 275,363 |
| 2012-03-15 | Uprichard David C (Director) | Sale | 200 | 46.08 | 9,216 |
| 2012-03-09 | Uprichard David C (Director) | Sale | 100 | 46.60 | 4,660 |
| 2012-03-08 | Uprichard David C (Director) | Sale | 200 | 46.56 | 9,313 |
| 2012-03-01 | Richard Kelli (Chief Accounting Officer) | Option Ex | 2,174 | 48.18 | 104,743 |
| 2012-02-27 | Uprichard David C (Director) | Sale | 500 | 47.66 | 23,827 |
| 2012-01-25 | Dittamore Raymond V (Director) | Sale | 20,000 | 50.65 | 1,013,000 |
| 2012-01-25 | Dittamore Raymond V (Director) | Option Ex | 20,000 | 17.56 | 351,200 |
| 2011-11-22 | Leddy Peter Michael (SVP, Global Human Resources) | Sale | 2,474 | 36.74 | 90,894 |
| 2011-11-21 | Stevenson Mark (President & COO) | Option Ex | 44,984 | 36.70 | 1,650,912 |
| 2011-11-21 | Leddy Peter Michael (SVP, Global Human Resources) | Option Ex | 24,741 | 36.70 | 907,994 |
| 2011-11-21 | Hoffmeister David F (Chief Financial Officer) | Option Ex | 41,610 | 36.70 | 1,527,087 |
| 2011-11-21 | Cottingham John A (Chief Legal Officer) | Option Ex | 24,741 | 36.70 | 907,994 |
| 2011-10-03 | Grimm Donald W (Director) | Option Ex | 4,052 | 37.21 | 150,774 |
| 2011-08-22 | Pescovitz Ora H. (Director) | Buy | 550 | 36.16 | 19,887 |
| 2011-08-22 | Stevenson Mark (President & COO) | Buy | 5,000 | 36.20 | 181,000 |
| 2011-08-22 | Lucier Gregory T (Chief Executive Officer) | Option Ex | 12,232 | 32.69 | 399,864 |
| 2011-08-22 | Uprichard David C (Director) | Option Ex | 400 | 31.86 | 12,744 |
| 2011-08-11 | Uprichard David C (Director) | Option Ex | 600 | 31.86 | 19,116 |
| 2011-08-05 | Lucier Gregory T (Chief Executive Officer) | Buy | 10,000 | 42.00 | 420,000 |
| 2011-06-07 | Uprichard David C (Director) | Sale | 1,000 | 51.04 | 51,040 |
| 2011-06-07 | Uprichard David C (Director) | Option Ex | 1,000 | 31.86 | 31,860 |
| 2011-05-16 | Leddy Peter Michael (SVP, Global Human Resources) | Option Ex | 3,414 | 55.62 | 189,886 |
| 2011-05-16 | Hoffmeister David F (Chief Financial Officer) | Option Ex | 3,200 | 55.62 | 177,984 |
| 2011-05-16 | Richard Kelli (Chief Accounting Officer) | Option Ex | 1,066 | 55.62 | 59,290 |
| 2011-05-16 | Cottingham John A (Chief Legal Officer) | Option Ex | 2,988 | 55.62 | 166,192 |
| 2011-05-03 | Uprichard David C (Director) | Sale | 4,000 | 55.44 | 221,752 |
| 2011-05-02 | Pescovitz Ora H. (Director) | Buy | 200 | 55.24 | 11,048 |
| 2011-05-02 | Uprichard David C (Director) | Option Ex | 4,052 | 55.44 | 224,642 |
| 2011-04-28 | Dittamore Raymond V (Director) | Option Ex | 4,052 | 55.96 | 226,749 |
| 2011-04-28 | Reynolds W Ann (Director) | Option Ex | 19,387 | 55.96 | 1,084,896 |
| 2011-03-15 | Grossman Paul David (SVP, Corporate Strategy & Dev.) | Sale | 18,556 | 50.40 | 935,129 |
| 2011-03-15 | Grossman Paul David (SVP, Corporate Strategy & Dev.) | Option Ex | 18,556 | 22.23 | 412,499 |
| 2011-03-15 | Levine Arnold J (Director) | Sale | 6,958 | 50.25 | 349,618 |
| 2011-03-15 | Levine Arnold J (Director) | Option Ex | 6,958 | 32.17 | 223,838 |
| 2011-03-11 | Adam George F Jr (Director) | Sale | 7,828 | 51.12 | 400,190 |
| 2011-03-11 | Adam George F Jr (Director) | Option Ex | 7,828 | 39.22 | 307,014 |
| 2011-02-24 | Uprichard David C (Director) | Sale | 100 | 52.61 | 5,261 |
| 2011-02-18 | Uprichard David C (Director) | Sale | 100 | 54.17 | 5,417 |
| 2011-02-15 | Uprichard David C (Director) | Sale | 100 | 54.33 | 5,432 |
| 2011-02-11 | Uprichard David C (Director) | Sale | 100 | 53.98 | 5,398 |
| 2011-02-09 | Uprichard David C (Director) | Sale | 100 | 53.55 | 5,355 |
| 2011-01-03 | Brust Bernd (President, Molecular Medicine) | Sale | 11,750 | 57.00 | 669,750 |
| 2011-01-03 | Brust Bernd (President, Molecular Medicine) | Option Ex | 11,750 | 28.30 | 332,525 |
| 2011-01-03 | Lorimier Bradley G (Director) | Sale | 20,000 | 56.24 | 1,124,189 |
| 2011-01-03 | Lorimier Bradley G (Director) | Option Ex | 20,000 | 33.31 | 666,199 |
| 2010-12-29 | Brust Bernd (President, Molecular Medicine) | Sale | 6,250 | 56.00 | 350,000 |
| 2010-12-29 | Brust Bernd (President, Molecular Medicine) | Option Ex | 6,250 | 27.51 | 171,937 |
| 2010-12-22 | Barthelemy Nicolas (Pres, Commercial Operations) | Option Ex | 3,036 | 32.94 | 100,005 |
| 2010-12-17 | Miller John L (President, Genetic Systems) | Sale | 31,208 | 55.41 | 1,725,119 |
| 2010-12-17 | Miller John L (President, Genetic Systems) | Option Ex | 31,208 | 22.23 | 693,753 |
| 2010-12-15 | Uprichard David C (Director) | Sale | 700 | 55.00 | 38,500 |
| 2010-12-15 | Uprichard David C (Director) | Option Ex | 500 | 35.53 | 17,765 |
| 2010-12-14 | Uprichard David C (Director) | Sale | 600 | 54.55 | 32,727 |
| 2010-12-14 | Uprichard David C (Director) | Option Ex | 500 | 35.53 | 17,765 |
| 2010-12-13 | Richard Kelli (Chief Accounting Officer) | Sale | 15,291 | 53.13 | 812,390 |
| 2010-12-13 | Richard Kelli (Chief Accounting Officer) | Option Ex | 15,291 | 32.06 | 489,971 |
| 2010-12-10 | Barthelemy Nicolas (Pres, Commercial Operations) | Sale | 31,208 | 52.80 | 1,647,876 |
| 2010-12-10 | Barthelemy Nicolas (Pres, Commercial Operations) | Option Ex | 31,208 | 22.23 | 693,753 |
| 2010-12-10 | Cottingham John A (Chief Legal Officer) | Sale | 38,400 | 52.75 | 2,025,600 |
| 2010-12-10 | Cottingham John A (Chief Legal Officer) | Option Ex | 38,400 | 22.82 | 876,288 |
| 2010-12-10 | Iyer Balakrishnan S (Director) | Sale | 20,000 | 52.73 | 1,053,588 |
| 2010-12-10 | Iyer Balakrishnan S (Director) | Option Ex | 20,000 | 30.59 | 611,800 |
| 2010-12-03 | Brust Bernd (Pres, Commercial Operations) | Sale | 31,208 | 52.99 | 1,653,711 |
| 2010-12-03 | Brust Bernd (Pres, Commercial Operations) | Option Ex | 31,208 | 22.23 | 693,753 |
| 2010-12-03 | Uprichard David C (Director) | Sale | 1,100 | 53.12 | 58,436 |
| 2010-12-03 | Uprichard David C (Director) | Option Ex | 1,000 | 35.53 | 35,530 |
| 2010-12-02 | Uprichard David C (Director) | Sale | 1,100 | 52.18 | 57,401 |
| 2010-12-02 | Uprichard David C (Director) | Option Ex | 1,000 | 31.86 | 31,860 |
| 2010-11-24 | Uprichard David C (Director) | Sale | 100 | 51.43 | 5,143 |
| 2010-11-22 | Grossman Paul David (SVP, Corporate Strategy & Dev.) | Sale | 14,029 | 50.35 | 706,388 |
| 2010-11-19 | Uprichard David C (Director) | Sale | 100 | 50.66 | 5,066 |
| 2010-11-17 | Uprichard David C (Director) | Sale | 100 | 49.74 | 4,974 |
| 2010-11-05 | Dittamore Raymond V (Director) | Sale | 20,000 | 51.69 | 1,033,740 |
| 2010-11-05 | Dittamore Raymond V (Director) | Option Ex | 20,000 | 30.59 | 611,800 |
| 2010-11-04 | Uprichard David C (Director) | Sale | 1,000 | 51.90 | 51,901 |
| 2010-11-04 | Uprichard David C (Director) | Option Ex | 1,000 | 31.86 | 31,860 |
| 2010-11-03 | Uprichard David C (Director) | Sale | 2,000 | 50.68 | 101,366 |
| 2010-11-03 | Uprichard David C (Director) | Option Ex | 2,000 | 33.70 | 67,390 |
| 2010-11-01 | Lucier Gregory T (Chief Executive Officer) | Sale | 62,868 | 50.40 | 3,168,798 |
| 2010-10-29 | Lucier Gregory T (Chief Executive Officer) | Sale | 100,000 | 50.30 | 5,030,500 |
| 2010-09-09 | Grimm Donald W (Director) | Sale | 20,000 | 46.50 | 929,920 |
| 2010-09-09 | Grimm Donald W (Director) | Option Ex | 20,000 | 33.31 | 666,200 |
| 2010-08-20 | Uprichard David C (Director) | Sale | 1,000 | 43.95 | 43,952 |
| 2010-08-20 | Uprichard David C (Director) | Option Ex | 1,000 | 31.86 | 31,860 |
| 2010-06-15 | Uprichard David C (Director) | Sale | 4,700 | 50.74 | 238,619 |
| 2010-06-15 | Uprichard David C (Director) | Option Ex | 4,000 | 34.61 | 138,448 |
| 2010-06-14 | Dansky Peter (Pres, Molecular Biology Sys) | Option Ex | 2,700 | 22.23 | 60,021 |
| 2010-06-14 | Uprichard David C (Director) | Sale | 99 | 50.60 | 5,009 |
| 2010-06-11 | Uprichard David C (Director) | Sale | 1,001 | 49.85 | 49,902 |
| 2010-06-11 | Uprichard David C (Director) | Option Ex | 1,000 | 33.70 | 33,695 |
| 2010-06-10 | Uprichard David C (Director) | Sale | 2,100 | 49.17 | 103,259 |
| 2010-06-10 | Uprichard David C (Director) | Option Ex | 2,000 | 34.31 | 68,614 |
| 2010-06-09 | Uprichard David C (Director) | Sale | 1,000 | 48.05 | 48,049 |
| 2010-06-09 | Uprichard David C (Director) | Option Ex | 1,000 | 33.70 | 33,695 |
| 2010-06-03 | Uprichard David C (Director) | Sale | 1,200 | 50.71 | 60,855 |
| 2010-06-03 | Uprichard David C (Director) | Option Ex | 1,000 | 33.70 | 33,695 |
| 2010-06-01 | Grossman Paul David (SVP, Corporate Strategy & Dev.) | Option Ex | 30,000 | 49.28 | 1,478,400 |
| 2010-05-28 | Uprichard David C (Director) | Sale | 1,000 | 50.16 | 50,160 |
| 2010-05-28 | Uprichard David C (Director) | Option Ex | 1,000 | 35.53 | 35,530 |
| 2010-05-27 | Uprichard David C (Director) | Sale | 1,200 | 50.01 | 60,012 |
| 2010-05-27 | Uprichard David C (Director) | Option Ex | 1,000 | 35.53 | 35,530 |
| 2010-05-26 | Uprichard David C (Director) | Sale | 1,000 | 49.18 | 49,182 |
| 2010-05-26 | Uprichard David C (Director) | Option Ex | 1,000 | 35.53 | 35,530 |
| 2010-05-21 | Uprichard David C (Director) | Sale | 2,000 | 48.35 | 96,702 |
| 2010-05-21 | Uprichard David C (Director) | Option Ex | 2,000 | 35.53 | 71,060 |
| 2010-05-18 | Miller John L (President, Genetic Systems) | Sale | 3,098 | 51.35 | 159,082 |
| 2010-05-17 | Brust Bernd (Pres, Commercial Operations) | Option Ex | 5,500 | 51.27 | 281,985 |
| 2010-05-17 | Miller John L (President, Genetic Systems) | Option Ex | 5,500 | 51.27 | 281,985 |
| 2010-05-17 | Leddy Peter Michael (SVP, Global Human Resources) | Option Ex | 5,300 | 51.27 | 271,731 |
| 2010-05-17 | Hoffmeister David F (Chief Financial Officer) | Option Ex | 5,300 | 51.27 | 271,731 |
| 2010-05-17 | Richard Kelli (Chief Accounting Officer) | Option Ex | 1,000 | 51.27 | 51,270 |
| 2010-05-17 | Barthelemy Nicolas (President, Cell Systems) | Option Ex | 5,300 | 51.27 | 271,731 |
| 2010-05-17 | Cottingham John A (Chief Legal Officer) | Option Ex | 5,300 | 51.27 | 271,731 |
| 2010-05-13 | Uprichard David C (Director) | Sale | 3,000 | 52.98 | 158,943 |
| 2010-05-13 | Uprichard David C (Director) | Option Ex | 3,000 | 36.18 | 108,540 |
| 2010-05-12 | Dansky Peter (Pres, Molecular Biology Sys) | Sale | 6,000 | 53.00 | 318,000 |
| 2010-05-12 | Dansky Peter (Pres, Molecular Biology Sys) | Option Ex | 6,000 | 22.23 | 133,380 |
| 2010-05-12 | Uprichard David C (Director) | Sale | 2,000 | 52.85 | 105,700 |
| 2010-05-12 | Uprichard David C (Director) | Option Ex | 2,000 | 31.86 | 63,720 |
| 2010-05-07 | Dansky Peter (Pres, Molecular Biology Sys) | Option Ex | 1,300 | 22.23 | 28,899 |
Insider trading activities including stock purchases, stock sales, and option exercises of IVGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Invitrogen Corp (symbol IVGN, CIK number 1073431) see the Securities and Exchange Commission (SEC) website.